Medical devices, healthcare technology and the business of care
510(k) clearance · K261617

Diagnostic Ultrasound System (Resona I10W);Diagnostic Ultrasound System (Resona I10 Exp);Diagnostic Ultrasound System (Resona I10);Diagnostic Ultrasound System (Resona I10S);Diagnostic Ultrasound System (Resona XI);Diagnostic Ultrasound System (Resona I10 CV);Diagnostic Ultrasound System (Nuewa I10W);Diagnostic Ultrasound System (Nuewa I10 Exp);Diagnostic Ultrasound System (Nuewa I10);Diagnostic Ultrasound System (Nuewa I10S);Diagnostic Ultrasound System (Nuewa XI);Diagnostic Ultrasoun

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Decision date Oct 8, 2026

MEDTECHLEDGER EXPLANATIONK261617

What did the FDA decide?

FDA recorded a substantially equivalent decision on 2026-10-08 for K261617, a traditional 510(k) from Shenzhen Mindray Bio-Medical Electronics Co., Ltd. The listed device name covers multiple Diagnostic Ultrasound System configurations under the Resona and Nuewa labels, including I10W, I10 Exp, I10, I10S, XI and I10 CV variants; the name field is truncated in the source, so the full model list is not established here. The application was received 05/15/2026 under regulation 892.1550, classification product code IYN, with subsequent codes ITX and IYO, in the Radiology specialty and review panel.

Substantially equivalent means FDA cleared the submission for marketing; it is not premarket approval of a new device. The record shows a traditional review not performed by a third party, no combination product status and no authorized predetermined change control plan. The summary statement itself is not included in the available text, so the specific indications, technological characteristics and any comparative testing supporting equivalence remain unknown. The page was last updated 11/16/2026.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Oct 8, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261617
Regulatory pathway
510(k) premarket notification
Product code
IYN
Decision code
SESE
Decision date
Oct 8, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: System, Imaging, Pulsed Doppler, Ultrasonic.

Product code
IYN
FDA device class
2

FDA decision timeline

  1. K261617 received

    Application receipt date recorded by FDA.

  2. K261617 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code IYN

Product / regulatory recordCompanyPathwayDecision dateSource
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.510(k) clearanceOct 16, 2026FDA
Samsung Medison Co., Ltd.510(k) clearanceOct 8, 2026FDA
GE Medical Systems Ultrasound and Primary care Diagnostics, LLC510(k) clearanceOct 2, 2026FDA
Philips Ultrasound, LLC510(k) clearanceSep 25, 2026FDA
Samsung Medison Co., Ltd.510(k) clearanceSep 25, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Shenzhen

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records